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Hypermethylation of the WTI and calcitonin gene
promoter regions at chromosome 11 p in human
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Summary The short arm of the chromosome 11, known to harbour a number of putative and established tumour-suppressor genes, is
frequently hypermethylated in various human neoplasms. We subjected the promoter regions of two genes residing at lip, namely the
tumour-suppressor gene WT1 (Wilms' tumour gene) (11p13) and the calcitonin gene (11p15.5), to methylation analysis in human sporadic
colorectal cancer using genomic sequencing. Both genes showed significant hypermethylation of CpG sites within their promoter regions in
adenomas and carcinomas compared with normal colonic mucosa. Although the WT1 promoter region was significantly hypermethylated, two
CpG sites located in Spl motifs were unmethylated in the majority of cases (68-74% of carcinomas). The expression of WT1 gene, as
revealed by in situ hybridization, showed no differences between normal colonic mucosa and malignant carcinoma. Together with earlier
observations, our present results support the view that the short arm of human chromosome 11 is subjected to widespread regional
hypermethylation in various human malignancies.
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For many years, changes in DNA methylation have been related to
cancer progression, yet the significance of these epigenetic alter-
ations to malignant transformation and progression has remained
unknown. During the past few years, the technical development of
methylation analysis of genomic DNA has made it possible to
study the methylation status ofindividual CpG sites with the aid of
genomic sequencing.
Hypermethylation of the regulatory sequences of genes usually
correlates with total silencing ofthe gene or its reduced expression
(Jones, 1996). Moreover, the methylation of the fifth carbon of
cytosine increases the risk of spontaneous deamination ofcytosine
to uracil, resulting in C to T transitions (Laird and Jaenisch, 1994),
as the mutation rate of 5-methylcytosine is 10- to 40-fold higher
than that of unmethylated cytosine. Therefore, the 5-methylcyto-
sine can be considered as an endogenous mutagen (Laird and
Jaenisch, 1994; Tornaletti and Pfeifer, 1995).
Hypermethylation-based inactivation of tumour-suppressor
genes may be one of the mechanisms leading to malignant trans-
formation. As hypermethylated genes can potentially be reacti-
vated by inhibition of DNA methylation (Jones, 1996), this may
offer a novel approach to cancer chemotherapy. Thus, the possi-
bility to demethylate tumour-suppressor genes and restore their
expression can be used as a means for therapeutic intervention in
cancer. In fact, inhibition of DNA methyltransferase by antisense
expression construct directed to the methyltransferase mRNA has
indicated that alteration in DNA methylation pattern can be suffi-
cient to reverse cell transformation (MacLeod and Szyf, 1995). In
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addition to hypermethylation of tumour-suppressor genes,
hypomethylation of oncogenes is also apparently involved in
malignant transformation and tumour progression. Thus, the
assessment of DNA methylation status of tumour-suppressor
genes and oncogenes would reveal potential targets for the therapy
based on the modification of DNA methylation.
In colorectal carcinogenesis, genomic hypomethylation (Goelz
et al, 1985; Feinberg et al, 1988) is an early epigenetic event
occurring in association with genetic changes, such as mutations in
the APC (adenomatous polyposis coli), DCC (deleted in colon
cancer) and p53 genes (Hamilton, 1992). The mutations of the
APC gene have been shown to be causally related to familial
adenomatous polyposis (FAP) (Cunningham and Dunlop, 1994).
FAP patients form multiple adenomatous polyps in early adult-
hood throughout the colon and rectum and have a high risk of
developing colon cancer. In addition to common genetic alter-
ations in colorectal cancer, c-myc oncogene hypomethylation has
been shown to occur in one-half of adenomas and two-thirds of
adenocarcinomas (Sharrard et al, 1992). While overall genomic
hypomethylation is associated with colorectal cancer (Goelz et al,
1985; Feinberg et al, 1988), some individual genes, such as the
oestrogen receptor gene (Issa et al, 1994) and the APC gene
(Hiltunen et al, i997), appear to be hypermethylated.
The short arm of human chromosome 11 harbours a number of
putative or established tumour-suppressor genes (Ichikawa et al,
1992; Lichy et al, 1992; Loh et al, 1992; Strohmeyer, 1993).
Interestingly, Ilp has been shown to be hypermethylated in
various human neoplasms (Bustros et al, 1988). The WTI gene
(lIpl3) is a tumour-suppressor gene that is expressed in a tissue-
restricted manner (Fraizer et al, 1994). The WT1 gene encodes a
transcription factor containing four zinc fingers at the carboxy
terminus with a proline-rich amino terminus and belongs to
the early growth response (EGR) family (Rauscher et al, 1990).
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Figure 1 The structures of the amplified promoter regions of WT1 (476 bp) and calcitonin (490 bp) genes. All analysed CpG sites are shown and the location
of SP-1 motifs as well as transcription initiation sites are depicted. A and B show the positions of selected primers for the second PCR. The calcitonin gene
structure is taken from Hakkarainen et al (1996)
To further characterize the methylation status of lIp in human
colorectal cancer, we subjected the promoter regions of WTI
(llpl3) and calcitonin (llplS.5) genes to base-specific methyla-
tion analysis with the aid ofgenomic sequencing. Our results indi-
cate that, while both genes are significantly more methylated in
tumour samples than in normal colonic mucosa, the expression of
the tumour-suppressor gene WTI is not depressed during progres-
sion ofcolorectal carcinogenesis.
MATERIALS AND METHODS
Sample collection and histology
Samples of normal colonic tissue, adenomas and malignant
tumours were collected in connection with surgical operations.
Tissue samples were immediately snap frozen and stored at -70°C
until sectioning. The microdissection (5 jum) of the frozen speci-
mens to remove normal tissue and the pathological anatomical
diagnosis (PAD) were performed by pathologists at Kuopio
University Hospital.
The protocol was approved by the Institutional Review
Committee ofthe Kuopio University Hospital.
In situ hybridization
Tissue samples were cut into 10-,um sections with a cryostat (Leica
CM3000, Germany) at -20°C, collected onto precleaned slides
(Menzel-Glaser, Germany) and processed for in situ hybridization
using the method as described in Schalling et al (1988). The
oligonucleotide probe (5'-CGGAGCCCA'TT'GCTGAGGCTCA-
GACCCGGACGCCCCGCGGCTCCTCCGGCCCTGG-3') used
was 3' end labelled using terminal deoxynucleotidyltransferase
(New England Nuclear, Boston, MA, USA) and 35S-labelled
deoxyadenosine triphosphate (New England Nuclear). After
hybridization, the sections were either exposed to Kodak XAR-5
film for 13 days or coated with Kodak NTB2 emulsion and
exposed for 18 days. Hybridization experiments, with non-specific
probe as well as hybridization in the presence of a 200-fold excess
of unlabelled WTI probe, were used to confirm the specificity of
the hybridization.
DNA extraction and bisulphite modification
Tissue samples (50-200 mg) from normal-appearing colonic
tissue were homogenized in 1 ml of 1 x PBS (phosphate-buffered
saline) and centrifuged for 5 min at 1000 g; the supematant frac-
tion was discarded and the pellet was homogenized in 500 jl of
x PBS. The homogenate was suspended in 5 ml of digestion
buffer (10 mm Tris, 1 mM EDTA, 0.3 M sodium acetate, 1%
sodium dodecyl sulphate, pH 8.0), and 50 jl of proteinase K
(Boehringer Mannheim, Germany) solution (20 mg ml-') was
added to each sample. Selected parts (cut in 5-gm sections) from
adenomas and adenocarcinomas were directly added to the diges-
tion buffer. The samples were incubated at +37°C for 12-18 h with
slow continuous shaking. Then RNAase A (Sigma, St Louis, MO,
USA) treatment was carried out by adding 50 jil of RNAase A
solution (10 mg ml-') to each sample followed by incubation at
+37°C for 30 min. The samples were extracted twice with 5 ml of
phenol and once with 5 ml of chloroform-isoamylalcohol (24:1)
mixture. DNA was precipitated with ethanol in the presence of3 M
sodium acetate. DNA was dissolved in Tris-EDTA buffer (10 mM
Tris-HCl, 1 mM EDTA, pH 8.0).
The DNA concentration was measured by Lambda Bio spec-
trometer (Perkin Elmer, Germany) and 10 jig ofDNA was used for
bisulphite modifications, which were carried out according to our
modified method (Myoihanen et al, 1994).
Amplification of the WT1 gene promoter region
Polymerase chain reaction (PCR) products were obtained by
carrying out two PCR reactions for each sample. In order to
amplify the WTI gene promoter region (Hofmann et al, 1993),
primers were selected to cover the region of 514 bp, from -509
to +5 with respect to transcription initiation site (GenBank
accession number X74840). For the amplification, 100 ng of
recently modified DNA was used in a 50-jl PCR mixture
containing: 20 pmol of the upper primer (5'-GATAGTTTTA-
GAAGTAAGAGTTAGATTTAAG-3'), 20 pmol of the lower
primer (5'-CCTAACTACCCTCAACTTCCC-3'), 1.0 mM magne-
sium chloride, 0.2 mm dNTPs and 1 x buffer. The conditions for
the first PCR cycle were +96°C for 4 min for denaturation and
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Figure 2 Average cytosine methylation of the WT1 (A) and calcitonin (B)
gene promoter regions. All 24 CpG sites of the WT1 promoter and all 25 CpG
sites of the calcitonin promoter were encountered. (A) Statistically significant
hypermethylation in the WT1 promoter was observed in both adenomas
(n = 8) and carcinomas (n = 19) compared with normal colonic tissue
(n = 14). The WT1 gene promoter was also significantly (P < 0.005) more
methylated in adenomas than in carcinomas. In B similar, but less
pronounced, hypermethylation was observed within the calcitonin gene
promoter region. Samples were obtained from normal colonic tissue (n = 14),
adenomas (n = 8) and carcinomas (n = 19), including carcinomas of the
sigmoid and ascending colon, caecum and rectum. The vertical bars
represent standard errors of the means and the asterisks illustrate the
statistical significance, ***P < 0.001
+80°C for 3 min, during which the DNA polymerase (Finnzymes)
was added. This was followed by 39 cycles each consisting of
+960C for 20 s for denaturation, 530C for 30 s for primer
annealing and +72°C for 90 s for extension, with a final extension
of5 min at +720C.
The product of the first PCR was diluted with water (1:100)
using aerosol-resistant tips, and 3 gl of the dilution was used for
the second PCR. Priniers for the second PCR were chosen to cover
the 476 bp included in the first PCR product. PCR reactions
were carried out in a 50-tl reaction mixture containing 5 pmol
of the upper primer (5'-CGTTGTAAAACGACGGCCAGTT-
TAAGGGTGTAAAGTAAGGGTA-3'), which has the first 21
bases for the universal primer, 5 pmol of the lower primer (5'-
CAACTTCCCAAAACTCAAAT-3') labelled with biotin and
1.0 mM magnesium chloride. The conditions for the first PCR
cycle were: +960C for 3 min and +80°C for 3 min. This was
followed by 33 cycles each consisting of +960C for 20 s, +520C
for 15 s, +72°C for 90 s and a final extension of5 min at +72°C.
The product ofthe second PCR was isolated using streptavidin-
coated magnetic beads (Dynal, Norway) according to the protocol
of the manufacturer.
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Figure 3 Average cytosine methylation of individual CpG sites within the
WT1 (A) and calcitonin (B) gene promoter regions in normal colonic mucosa,
adenoma and carcinoma. A shows the significantly higher CpG methylation
in adenomas and carcinomas than in normal colonic mucosa. The WT1
promoter region contains two Spl motifs, of which CpG dinucleotide
methylation was significantly less in carcinomas and adenomas than in other
dinucleotides studied. Samples were obtained from normal colonic tissue
(n = 14), adenomas (n = 8) and carcinomas (n = 19), including carcinomas of
the sigmoid and ascending colon, caecum and rectum
Amplification of the calcitonin gene promoter region
The amplification was carried out according to our recently devel-
oped method (Hakkarainen et al, 1996). In brief, primers for first
PCR were selected to cover a 517-nucleotide region (GenBank
accession number X15943). The reaction mixture for PCR
contained 20 pmol of the upper primer (5'-TATIlTGGTAGGGT-
TTGGATrAGA-3'), 20 pmol of the lower primer (5'-CCAAAA-
TCTCG/AAAACTCACCTAAC-3'), 1.5 mM magnesium chloride
and 0.2 mm dNTPs (Finnzymes). Conditions for the first PCR were
+96°C for 3 min and +80°C for 3 min. This was followed by 37
cycles each consisting of+96°C for 15 s, +560C for 15 s, +720C for
90 s and a final extension of 5 min at +72°C.
Primers for the second PCR were chosen to cover a region of
490 nucleotides. The reaction mixture contained 5 pmol of the
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Figure 4 Micrographs showing WT1 mRNA expression in normal colonic tissue (A and D) and in carcinoma (E) detected using in situ hybridization. In an
autoradiograph (A) and in an emulsion-covered section (B), a strong hybridization signal is detected over the mucosa (MU) compared with the submucosa
(SM). At high power, in a section counterstained with haematoxylin, the silver grains are mainly located on the epithelial cells (arrow heads). Few grains are
located on the muscularis mucosae (m). Compared with the epithelial cells in the control tissue (D), practically the same grain density is seen in carcinoma cells
(E), with an average of 70% methylated WT1 promoter. Bar = 100 gm (B), 40 ,um (C) and 20 ,um (D and E)
upper primer (5'-GTAAAACGACGGCCAGTlFlTGGATTAGA-
GTITGGAAGAGTT-3'), 5 pmol ofthe lowerprimer(5'-CTCACC-
TAACA/GAAAAATAACTTAAATC-3') and 1.5 mm magnesium
chloride. Conditions for the first PCR were +96°C for 3 min and
+80°C for 3 min. This was followedby 30cycles eachconsisting of
+960C for 15 s, +560C for 15 s, +72°C for 90 s and a final exten-
sion at +72°C for 5 min.
Sequencing reactions
The sequencing reactions for the products ofthe second PCR were
carried outusing the AutoRead kit (Pharmacia, Sweden) with fluo-
rescently labelled primers. Reaction products were analysed on the
ALF (Pharmacia) DNA sequencer using the AM V3.02 program.
The methylation status of the final sequence was evaluated by
grading the CpG methylation into five categories: 100%, 75%,
50%, 25% and 0%, as described in Myohanen et al (1994).
Statistical analyses
The two-tailed Student's t-test was used to evaluate the statistical
significances.
RESULTS
Methylation of the WT1 promoter region in normal
colonic mucosa, premalignant adenoma and colorectal
carcinoma
Genomic sequencing was used to analyse the methylation of the
WTI tumour-suppressor gene promoter region. The method
consists of DNA modification with the aid of bisulphite, PCR
amplification of the selected region from modified DNA and
direct sequencing ofthe PCR product. The amplified region ofthe
WTI gene promoter contains, altogether, 28 CpG dinucleotides,
for which the methylation status of the first 24 CpG sites was
determined (Figure 1). The amplified region also contains two SpI
motifs 5'-CCCGCCC-3' (Fraizer et al, 1994), including CpG sites
3 and 16. In the normal colonic tissue (n = 14), the WTI gene
promoter was completely unmethylated, whereas the base-specific
analysis ofmethylated cytosines revealed significant hypermethyl-
ation in premalignant adenomas (n = 8) and, to a slightly lesser
extent, in carcinomas (n = 19), as shown in Figure 2. As shown in
Figure 3A, the CpG site 3 within the first Spl motifwas unmethyl-
ated in 74% (14 out of 19) of cancers and the CpG site 16 within
the second Spl motif was unmethylated in 68% (13 out of 19) of
cancers. The observation was similar in adenomas in which the
first Spl motif was unmethylated in 50% of cases and the second
Spl motif was unmethylated in 63% of cases. In normal colonic
tissue, all samples examined showed completely unmethylated
Spl motifs.
Methylation of the calcitonin gene promoter in normal
colonic mucosa, adenoma and colorectal carcinoma
We used the same methodology to study the methylation status of
the calcitonin gene promoter in colorectal cancer. For genomic
sequencing, we used a 490-nucleotide fragment (covering the
nucleotides -379 to +110 with respect to transcription start site)
amplified after bisulphite modification. This fragment contained
26 CpG dinucleotides, ofwhich the methylation status for the first
25 CpG sites was determined. As shown in Figure 2, the calcitonin
gene promoter was significantly more methylated in adenomas
(n = 8) and carcinomas (n = 419) than in normal colonic mucosa
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Figure 5 Raw sequence data from the ALF DNA Sequencer. A represents the methylation pattern of the WT1 gene promoter in a carcinoma sample from
caecum. Thin arrows point to putative methylation positions. The numbering of CpG sites corresponds to their exact locations in the amplified sequence. In B,
the methylation status of the calcitonin gene promoter from the same tumour is shown. The thick arrow points to a CpG site located in the SP1 motif. The
original unmodified sequence is given under the modified DNA sequence. The methylation value is as follows: CpG site 7, 100%; CpG site 8, 75%; CpG site 3,
75%; and CpG site 4, 50%
(n = 14). The amplified calcitonin gene promoter region also
contains two putative Sp1 motifs (Figures 1 and 3), but there were
no significant differences in methylation status between CpG sites
located to Spl motifs and other CpG dinucleotides, as seen in the
WTI promoter region. In Figure 5, raw sequence data illustrate the
primary outcome ofmodified and PCR amplified DNA.
Expression and localization of the WT1 mRNA in
normal colonic mucosa and colorectal carcinoma
Because ofthe heterogeneous cell population in colonic tissue, the
in situ hybridization method was selected to analyse localization
and intensity of WTJ mRNA expression in normal colonic tissue
and in carcinomas. The WTI mRNA was expressed in epithelial
cells of normal colonic mucosa as shown in Figure 4A and D.
As also shown in Figure 4E, a quantitatively similar expression
pattern was seen in tumour samples, in spite of the fact that the
promoter region ofthe WTI gene was on average 70% methylated
in comparison with the totally unmethylated control samples.
DISCUSSION
Two types of DNA methylation changes appear to be connected, at
least potentially, with the progression of malignant tumours:
hypomethylation-induced activation of oncogenes and hyper-
methylation-based silencing of tumour-suppressor genes (Laird and
Jaenisch, 1994). Almost all of the methylation studies have so far
been carried out with methylation-sensitive restriction enzymes.
Although giving clear-cut changes in DNA methylation status of a
given gene, these methodologies do not uncover base-specific
changes in cytosine methylation. In this respect, genomic sequencing
is superior to others methods as it can be used for detailed methyla-
tion analyses ofthe promoter regions ofknown genes.
Even though most of the studies elucidating the relationship
between DNA methylation and tumour progression have been
of a descriptive nature (Jones, 1996), some recent reports suggest
that a modification of gene methylation can be used as a thera-
peutic approach. In fact, DNA methyltransferase enzyme has
been successfully inhibited in vitro by an antisense technique
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that resulted in limited genomic hypomethylation that was associ-
ated with a reversal of malignant transformation (MacLeod and
Szyf, 1995).
The molecular carcinogenesis of human colorectal cancer is
relatively well known. It involves distinctly ordered alterations in
common oncogenes and tumour-suppressor genes (Hamilton,
1992). Genomic hypomethylation is a special feature of colorectal
cancer occurring at an early stage ofthe disease (Goelz et al, 1985;
Feinberg et al, 1988), although regional hypermethylation (Issa et
al, 1994; Hiltunen et al, 1997) and increased activity of DNA
methyltransferase (Issa et al, 1993) have also been reported with
progression ofthe tumour.
We recently developed a method making it possible to eluci-
date base-specific methylation status of any known sequence of
interest (Myohanen et al, 1994). By using this method, we
showed that the calcitonin gene was distinctly hypermethylated in
breast cancer (Hakkarainen et al, 1996). Here, we show that the
promoter of the calcitonin gene is likewise hypermethylated in
colorectal cancer. The calcitonin gene hypermethylation in
premalignant colonic adenomas and in carcinomas has already
been reported using restriction endonucleases (Silverman et al,
1989). We also subjected the promoter region ofthe WTI tumour-
suppressor gene, another gene residing at the short arm of chro-
mosome 11, to genomic sequencing and found that it was
significantly more methylated in colorectal cancer than in normal
mucosa. However, this methylation of the WTI gene apparently
did not affect its expression as revealed by in situ hybridization
experiments. WTI gene expression was limited to the epithelial
cells ofboth the normal mucosa and the tumours. The observation
that 70-80% methylation of the CpG sites of the promoter region
of the WTI gene did not appear to have as effect on its expression
(Figure 4) suggests that this gene is mainly regulated by factors
other than DNA methylation. The facts that the CpG sites within
Spl motifs were significantly less methylated than other CpG
dinucleotides (Figure 3) and that the mRNA expression was not
altered may indicate an involvement of Spl-based regulation. If
WTI expression is required in the cell, the important sites for tran-
scription will be protected from DNA methylation to allow
constitutive expression ofthe gene. This might also be the case, at
least for some ofthe reported gene hypermethylations, in cancers.
Thus, it is important to study the corresponding mRNA expres-
sion with gene methylation, and each gene should be considered
individually. Although the expression ofthe WTI gene appears to
be tightly regulated throughout development, its promoter readily
functions in all cell lines tested. The gene seems to contain a tran-
scriptional silencer element in the third intron (Hewitt et al,
1995). In addition to this silencer, the WTI gene
has been reported to possess a functional antisense promoter
located in the first intron that negatively regulates gene expres-
sion (Malik et al, 1995).
Our results show constitutive epithelial cell-localized expres-
sion of the WT] tumour suppressor gene in the progression of
colorectal cancer and, in addition, genomic sequencing results
support the notion that the short arm of human chromosome 11 is
subjected to widespread regional hypermethylation in human
colorectal cancer.
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